Tomohiko Tsuruta

590 total citations
16 papers, 448 citations indexed

About

Tomohiko Tsuruta is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Cancer Research. According to data from OpenAlex, Tomohiko Tsuruta has authored 16 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Reproductive Medicine, 5 papers in Obstetrics and Gynecology and 5 papers in Cancer Research. Recurrent topics in Tomohiko Tsuruta's work include Endometrial and Cervical Cancer Treatments (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Genetic factors in colorectal cancer (4 papers). Tomohiko Tsuruta is often cited by papers focused on Endometrial and Cervical Cancer Treatments (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Genetic factors in colorectal cancer (4 papers). Tomohiko Tsuruta collaborates with scholars based in Japan and Armenia. Tomohiko Tsuruta's co-authors include Johji Inazawa, Atsushi Uesugi, Issei Imoto, Mayuko Furuta, Ken‐ichi Kozaki, K. Morita, Ken Omura, Akira Hirasawa, Nobuyuki Susumu and Daisuke Aoki and has published in prestigious journals such as Cancer Research, Japanese Journal of Clinical Oncology and Nuclear Medicine Communications.

In The Last Decade

Tomohiko Tsuruta

13 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomohiko Tsuruta Japan 5 361 336 35 25 24 16 448
Zhicheng Yu China 10 207 0.6× 168 0.5× 50 1.4× 15 0.6× 24 1.0× 22 320
Tae Hoen Kim South Korea 10 276 0.8× 248 0.7× 60 1.7× 45 1.8× 34 1.4× 17 386
Strahil Georgiev Switzerland 5 267 0.7× 189 0.6× 29 0.8× 14 0.6× 21 0.9× 7 352
M Chen China 7 228 0.6× 183 0.5× 63 1.8× 23 0.9× 7 0.3× 16 370
Zhongzu Zhang China 13 276 0.8× 256 0.8× 36 1.0× 6 0.2× 8 0.3× 17 391
K. М. Nyushko Russia 14 287 0.8× 256 0.8× 57 1.6× 6 0.2× 13 0.5× 78 444
Tracy Litzi United States 10 192 0.5× 110 0.3× 63 1.8× 49 2.0× 64 2.7× 14 313
Minuo Yin China 8 265 0.7× 212 0.6× 42 1.2× 63 2.5× 57 2.4× 9 440
Jie Xi China 10 214 0.6× 192 0.6× 24 0.7× 14 0.6× 5 0.2× 16 296
Haojie Dong China 10 220 0.6× 150 0.4× 26 0.7× 6 0.2× 6 0.3× 22 305

Countries citing papers authored by Tomohiko Tsuruta

Since Specialization
Citations

This map shows the geographic impact of Tomohiko Tsuruta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiko Tsuruta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiko Tsuruta more than expected).

Fields of papers citing papers by Tomohiko Tsuruta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohiko Tsuruta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiko Tsuruta. The network helps show where Tomohiko Tsuruta may publish in the future.

Co-authorship network of co-authors of Tomohiko Tsuruta

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiko Tsuruta. A scholar is included among the top collaborators of Tomohiko Tsuruta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiko Tsuruta. Tomohiko Tsuruta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Norikane, Takashi, Yuka Yamamoto, Tamaki Tanaka, et al.. (2022). Correlation of bone marrow 2-deoxy-2-[18F]fluoro-D-glucose uptake with systemic inflammation in patients with newly diagnosed endometrial cancer. Nuclear Medicine Communications. 43(8). 916–921. 2 indexed citations
2.
Tsuruta, Tomohiko, Yukiharu Todo, R Yamada, et al.. (2022). Initial screening by immunohistochemistry is effective in universal screening for Lynch syndrome in endometrial cancer patients: a prospective observational study. Japanese Journal of Clinical Oncology. 52(7). 752–758. 1 indexed citations
3.
Yamada, R, Tomohiko Tsuruta, Yukiharu Todo, et al.. (2021). Validity of skeletal muscle mass index measurements for assessing sarcopenia in patients with gynecological cancer. Japanese Journal of Clinical Oncology. 51(10). 1534–1540. 1 indexed citations
5.
Yamada, R, Yukiharu Todo, Tomohiko Tsuruta, et al.. (2020). Validity of measuring psoas muscle mass index for assessing sarcopenia in patients with gynecological cancer. Japanese Journal of Clinical Oncology. 51(3). 393–399. 10 indexed citations
6.
Todo, Yukiharu, Hiroyuki Yamazaki, R Yamada, et al.. (2020). Diagnostic criteria of sentinel lymph node micrometastasis or macrometastasis based on tissue rinse liquid-based cytology in gynecological cancer. International Journal of Clinical Oncology. 25(12). 2138–2143. 1 indexed citations
7.
Todo, Yukiharu, R Yamada, Tomohiko Tsuruta, et al.. (2020). Clinical implication of psoas muscle mass measurement for predicting death within 3 months in patients with incurable uterine cervical or corpus malignancy. Japanese Journal of Clinical Oncology. 51(4). 577–583. 2 indexed citations
8.
Todo, Yukiharu, et al.. (2020). A BMI-category distribution pattern of intrinsic and treatment-related prognostic factors in endometrial cancer. Japanese Journal of Clinical Oncology. 51(5). 722–727. 4 indexed citations
9.
Yamazaki, Hiroyuki, et al.. (2019). Imaging-based definition of lower uterine segment carcinoma to improve the detection sensitivity of probable Lynch syndrome. Japanese Journal of Clinical Oncology. 50(3). 270–275. 1 indexed citations
10.
Tsuruta, Tomohiko, et al.. (2016). [A Retrospective Case Study of Combination Chemotherapy with Bevacizumab for Recurrent Ovarian Cancer].. PubMed. 43(10). 1197–1200.
11.
Murakami, Junko, et al.. (2016). [A Case of Bilateral Pneumothorax after Chemotherapy for Uterine Leiomyosarcoma with Multiple Lung Metastases].. PubMed. 43(2). 259–61. 1 indexed citations
12.
Hirasawa, Akira, Kenta Masuda, Tomoko Akahane, et al.. (2013). Family History and BRCA1/BRCA2 Status Among Japanese Ovarian Cancer Patients and Occult Cancer in a BRCA1 Mutant Case. Japanese Journal of Clinical Oncology. 44(1). 49–56. 11 indexed citations
14.
Hirasawa, Akira, Tomohiko Tsuruta, Kouji Banno, Nobuyuki Susumu, & Daisuke Aoki. (2012). [Hereditary endometrial cancer and genetic testing].. PubMed. 70 Suppl 4. 292–6.
15.
Uesugi, Atsushi, Ken‐ichi Kozaki, Tomohiko Tsuruta, et al.. (2011). The Tumor Suppressive MicroRNA miR-218 Targets the mTOR Component Rictor and Inhibits AKT Phosphorylation in Oral Cancer. Cancer Research. 71(17). 5765–5778. 216 indexed citations
16.
Tsuruta, Tomohiko, Ken‐ichi Kozaki, Atsushi Uesugi, et al.. (2011). miR-152 Is a Tumor Suppressor microRNA That Is Silenced by DNA Hypermethylation in Endometrial Cancer. Cancer Research. 71(20). 6450–6462. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026